The Medical Letter on Drugs and Therapeutics
FROM
ISSUE
1579
August 26, 2019
View Complete Issue         Table of Contents 2019 
Issue 1579
Subscribers: Log in to read full issue.  Not a subscriber?  Subscribe or purchase issue.
Note: Zolgensma Data Manipulation
August 26, 2019 (Issue: 1579)
On August 6, 2019, the FDA issued a statement on data manipulation/inaccuracy issues with Zolgensma, a virus vector-based gene therapy approved for one-time IV treatment of children <2 years old with spinal muscular atrophy.1 We reviewed Zolgensma...more
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.

Would you like to read the rest of this issue?  Gain access below.

Subscribe
Subscriptions to The Medical Letter on Drugs and Therapeutics include:
  • Print version published and mailed biweekly (26 issues/year)
  • Unlimited online access to current and past issues (1988 - present)
  • Mobile App
  • FREE online per issue CME/CE
Purchase this issue:
Title: Issue 1579
 


Gain access through your organization
Ask your librarian to consider an Institutional Subscription to The Medical Letter.